Literature DB >> 31950014

Takotsubo cardiomyopathy caused by infusion reaction to trastuzumab.

Toshihiko Matsumoto1, Takashi Oda1, Yu Yoshida2, Shogo Kimura1, Hitomi Himei1, Takao Tsuduki1, Shinjiro Takagi1, Masahiro Takatani1, Hirofumi Morishita1.   

Abstract

Takotsubo cardiomyopathy (TCM) is also known as stress-induced cardiomyopathy. The occurrence of TCM due to infusion reaction is extremely rare. A 65-year-old man began receiving trastuzumab monotherapy for gastric cancer. However, he developed an infusion reaction after administration. Electrocardiography revealed negative T waves, ST segment elevation, and apical akinesis and hypokinesis of the left ventricle with apical ballooning in the systole and diastole. Furthermore, troponin I and creatinine kinase (CK) levels and CK-myocardial band were elevated. Based on these findings, he was diagnosed with TCM. This is the first report of TCM due to an infusion reaction. © The Japan Society of Clinical Oncology 2019.

Entities:  

Keywords:  Chemotherapy; Infusion reaction; Takotsubo cardiomyopathy

Year:  2019        PMID: 31950014      PMCID: PMC6942559          DOI: 10.1007/s13691-019-00396-0

Source DB:  PubMed          Journal:  Int Cancer Conf J        ISSN: 2192-3183


  18 in total

1.  5-Fluorouracil-induced Tako-Tsubo-like syndrome.

Authors:  Cécile Basselin; Thierry Fontanges; Jacques Descotes; Philippe Chevalier; Bernard Bui-Xuan; Gwennaelle Feinard; Quadiri Timour
Journal:  Pharmacotherapy       Date:  2011-02       Impact factor: 4.705

Review 2.  Takotsubo cardiomyopathy and Fluorouracil: case report and review of the literature.

Authors:  Michael R Grunwald; Lynn Howie; Luis Alberto Diaz
Journal:  J Clin Oncol       Date:  2011-12-05       Impact factor: 44.544

3.  Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.

Authors:  T Stewart; N Pavlakis; M Ward
Journal:  Intern Med J       Date:  2010-04       Impact factor: 2.048

4.  Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.

Authors:  Michael S Ewer; Mary T Vooletich; Jean-Bernard Durand; Myrshia L Woods; Joseph R Davis; Vicente Valero; Daniel J Lenihan
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

5.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy.

Authors:  Ingo Eitel; Florian von Knobelsdorff-Brenkenhoff; Peter Bernhardt; Iacopo Carbone; Kai Muellerleile; Annachiara Aldrovandi; Marco Francone; Steffen Desch; Matthias Gutberlet; Oliver Strohm; Gerhard Schuler; Jeanette Schulz-Menger; Holger Thiele; Matthias G Friedrich
Journal:  JAMA       Date:  2011-07-20       Impact factor: 56.272

6.  Clinical cardiotoxicity of 5-fluorouracil.

Authors:  D L Keefe; N Roistacher; M K Pierri
Journal:  J Clin Pharmacol       Date:  1993-11       Impact factor: 3.126

7.  Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel.

Authors:  Brian Leyland-Jones; Karen Gelmon; Jean-Pierre Ayoub; Andrew Arnold; Shail Verma; Reg Dias; Parviz Ghahramani
Journal:  J Clin Oncol       Date:  2003-09-24       Impact factor: 44.544

8.  Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors.

Authors:  Alberto Farolfi; Elisabetta Melegari; Michele Aquilina; Emanuela Scarpi; Toni Ibrahim; Roberta Maltoni; Samanta Sarti; Lorenzo Cecconetto; Elisabetta Pietri; Cristiano Ferrario; Anna Fedeli; Marina Faedi; Oriana Nanni; Giovanni Luca Frassineti; Dino Amadori; Andrea Rocca
Journal:  Heart       Date:  2013-01-24       Impact factor: 5.994

Review 9.  Trastuzumab-induced cardiotoxicity: heart failure at the crossroads.

Authors:  Partho P Sengupta; Donald W Northfelt; Federico Gentile; Jose L Zamorano; Bijoy K Khandheria
Journal:  Mayo Clin Proc       Date:  2008-02       Impact factor: 7.616

10.  5 flourouracil-induced apical ballooning syndrome: a case report.

Authors:  Monica Gianni; Francesco Dentali; Eva Lonn
Journal:  Blood Coagul Fibrinolysis       Date:  2009-06       Impact factor: 1.276

View more
  1 in total

Review 1.  Update of Takotsubo cardiomyopathy: Present experience and outlook for the future.

Authors:  Anastasiia V Bairashevskaia; Sofiya Y Belogubova; Mikhail R Kondratiuk; Daria S Rudnova; Susanna S Sologova; Olga I Tereshkina; Esma I Avakyan
Journal:  Int J Cardiol Heart Vasc       Date:  2022-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.